Cargando…
Strategies for senolytic drug discovery
Senolytics are a category of drugs that reduce the impact of cellular senescence, an effect associated with a range of chronic and age‐related diseases. Since the discovery of the first senolytics in 2015, the number of known senolytic agents has grown dramatically. This review discusses the broad c...
Autores principales: | Power, Helen, Valtchev, Peter, Dehghani, Fariba, Schindeler, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577556/ https://www.ncbi.nlm.nih.gov/pubmed/37548098 http://dx.doi.org/10.1111/acel.13948 |
Ejemplares similares
-
Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein
por: Power, Helen, et al.
Publicado: (2022) -
Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D
por: Wu, Jiadai, et al.
Publicado: (2022) -
Citrus Peel Flavonoids as Potential Cancer Prevention Agents
por: Koolaji, Nooshin, et al.
Publicado: (2020) -
Dynamic flow and shear stress as key parameters for intestinal cells morphology and polarization in an organ-on-a-chip model
por: Fois, Chiara A. M., et al.
Publicado: (2021) -
Senolytic drugs: from discovery to translation
por: Kirkland, J. L., et al.
Publicado: (2020)